Burden and risk factors of cutaneous leishmaniasis in Ethiopia: a systematic review and meta-analysis
Corresponding Author
Endalew Yizengaw Shita MSc
Department of Medical Laboratory Science, College of Medicine and Health science, Bahir Dar University, Bahir Dar, Ethiopia
Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
Correspondence
Endalew Yizengaw Shita, msc
Department of Medical Laboratory Science
College of Medicine and Health Science
Bahir Dar University
Bahir Dar, Ethiopia
E-mail: [email protected]
Search for more papers by this authorEndalkachew Nibret PhD
Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
Search for more papers by this authorAbaineh Munshea PhD
Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
Search for more papers by this authorBizuayehu Gashaw MSc
Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
Search for more papers by this authorCorresponding Author
Endalew Yizengaw Shita MSc
Department of Medical Laboratory Science, College of Medicine and Health science, Bahir Dar University, Bahir Dar, Ethiopia
Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
Correspondence
Endalew Yizengaw Shita, msc
Department of Medical Laboratory Science
College of Medicine and Health Science
Bahir Dar University
Bahir Dar, Ethiopia
E-mail: [email protected]
Search for more papers by this authorEndalkachew Nibret PhD
Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
Search for more papers by this authorAbaineh Munshea PhD
Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia
Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
Search for more papers by this authorBizuayehu Gashaw MSc
Department of Biology, College of Science, Bahir Dar University, Bahir Dar, Ethiopia
Search for more papers by this authorConflict of interest: None.
Funding source: None.
Abstract
Introduction
Cutaneous leishmaniasis (CL) is a major public health problem in Ethiopia. About 30 million people are at risk, and there are 20,000 to 50,000 new cases annually. It is maintained by rock hyraxes and Phlebotomus sand flies. Different studies showed the presence and risk factors of CL. However, there is no study on the pooled prevalence and risk factors. This study aimed to determine the pooled prevalence and risk factors of CL in Ethiopia.
Method
We retrieved published articles from different databases. The review was conducted based on PRISMA guidelines. The meta-analysis was done with Stata software version 14. The forest plot with random-effect model and inverse variance index was used to estimate the pooled prevalence with 95% confidence interval and heterogeneity of articles, respectively.
Results
A total of 99,226 people from 19 studies were screened. The overall pooled prevalence of CL was 20.4% with 95% CI (15.67–25.13%). The pooled prevalence is a weighted average of results of the included 19 studies. Highest pooled prevalence, 65.39% (95% CI: 61.14–69.47%), was in Southern Nations, Nationalities and Peoples' Region (SNNPR), and the lowest was 1.53% (95% CI: 1.43–1.63%) in Amhara Region. Children were the most affected age group. Living in a home close to farmlands, outdoor sleeping behavior, the presence of gorge, hyrax, cracked walls, animal dung, and other cases in the neighborhood were identified as risk factors for CL.
Conclusion
There is high burden of CL in Ethiopia. Larger surveys are required. Health education on the prevention and control strategies shall be implemented.
Open Research
Data Availability Statement
The datasets used and/or analyzed during this study are available from the corresponding author on request.
References
- 1Ruiz-Postigo JA, Grout L, Jain S. Global leishmaniasis surveillance, 2017–2018, and first report on 5 additional indicators. Wkly Epidemiol Rec 2020; 25: 165–280.
- 2Steverding D. The history of leishmaniasis. Parasit Vectors 2017; 10: 1–10.
- 3Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet Seminar 2018; 392: 951.
- 4Singh OP, Sundar S. Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Front Immunol 2014; 5: 296.
- 5Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishmaniasis. Lancet Infect Dis 2007; 7: 581–596.
- 6 Control of the leishmaniases. WHO Technical report 2010: 16–202.
- 7Umi Azizah U, Nurdian Y. New World leishmania more severe than Old World leishmania: New World Species Cause a Spectrum of Disease Ranging from Mild Cutaneous Disease to Severe Mucosal Lesions 2017: 1–4.
- 8Alvar J, Canavate C, Gutierrez-Solar B, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10: 298–319.
- 9Dalys GBD et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 2015; 386: 2145–2191.
- 10Bern C, Maguire JH, Alvar J. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl Trop Dis 2008; 2: 1–10.
- 11Deribe K, Meribo K, Gebre T, et al. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors 2012; 5: 1–15.
- 12Negera E, Gadisa E, Yamuah L, et al. Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification. Trans R Soc Trop Med Hyg 2008; 102: 883–890.
- 13Padovese V, Terranova M, Toma L, et al. Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: Clinical aspects and therapeutic concerns. Trans R Soc Trop Med Hyg 2009; 103: 707–711.
- 14 Guideline for Diagnosis, Treatment and Prevention of Leishmaniasis in Ethiopia 2013. https://www.afrikadia.org/wp-content/uploads/2018/08/VL_Guidelines_Ethiopia_2013.pdf
- 15Bray R, Ashford R, Bray M. The parasite causing cutaneous leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg 1973; 67: 345–348.
- 16Seid A, Gadisa E, Tsegaw T, et al. Risk map for cutaneous leishmaniasis in Ethiopia based on environmental factors as revealed by geographical information systems and statistics. Geospat Health 2014; 8: 377–387.
- 17Hailu A, Di Muccio T, Abebe T, et al. Isolation of leishmania tropica from an Ethiopian cutaneous leishmaniasis patient. Trans R Soc Trop Med Hyg 2006; 100: 53–58.
- 18Ashford R, Bray MA, Hutchinson MP, et al. The epidemiology of cutaneous leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg 1973; 67: 568–601.
- 19 WHO. The leishmaniases: WHO, Geneva. World Health Organ Tech Rep Ser 1984; 1984: 701.
- 20Convit J, Ulrich M, Fernandez CT, et al. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 1993; 87: 444–448.
- 21Hofstraat K, van Brakel WH. Social stigma towards neglected tropical diseases: a systematic review. Int Health 2016; 8: i53–i70.
- 22Bailey F, Mondragon-Shem K, Hotez P, et al. A new perspective on cutaneous leishmaniasis-implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis 2017; 11: 2–6.
- 23Bennis I, Belaid L, De Brouwere V, et al. “The mosquitoes that destroy your face.” Social impact of cutaneous leishmaniasis in South-Eastern Morocco, a qualitative study. PLoS One 2017; 12: 1–13.
- 24Bennis I, Thys S, Filali H, et al. Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia province, Morocco. Infect Dis Poverty 2017; 7: 46.
- 25Gimbel DC, Legesse TB. Dermatopathology practice in Ethiopia. Arch Pathol Lab Med 2013; 137: 798–804.
- 26Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and metaanalyses: The PRISMA statement. PLoS Med 2009; 6: 1–7.
- 27Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603–605.
- 28Biggerstaff BJ, Tweedie RL. Incorporating variability estimates of heterogeneity in the random effects model in meta-analysis. Stat Med 1997; 16: 753–768.
10.1002/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G CAS PubMed Web of Science® Google Scholar
- 29Merdekios B, Pareyn M, Tadesse D, et al. Detection of cutaneous leishmaniasis foci in South Ethiopia. Am J Trop Med Hyg 2021; 1–3: 156–158.
- 30Zeleke AJ, Derso A, Yeshanew A, et al. A ten-year trend of cutaneous leishmaniasis at University of Gondar Hospital, Northwest Ethiopia: 2009–2018. J Parasitol Res 2021; 2021: 1–7.
- 31Sunyoto T, Verdonck K, el Safi S, et al. Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa—a systematic review. PLoS Negl Trop Dis 2018; 12: 1–20.
- 32Tamiru HF, Mashalla YJ, Mohammed R, et al. Cutaneous leishmaniasis a neglected tropical disease: community knowledge, attitude and practices in an endemic area, Northwest Ethiopia. BMC Infect Dis 2019; 19: 2–10.
- 33Tesfay K, Mardu F, Berhe B, et al. Household knowledge, practice and treatment seeking behaviors towards cutaneous leishmaniasis in the endemic rural communities of Ganta- afeshum district, Tigrai, northern Ethiopia, 2019: A cross-sectional study. Trop Dis Travel Med Vaccines 2021; 7: 1–10.
- 34Alidosti M, Heidari Z, Shahnazi H, et al. Behaviors and perceptions related to cutaneous leishmaniasis in endemic areas of the world: a review. Acta Trop 2021; 223: 1–11.
- 35Bisetegn H, Zeleke AJ, Gadisa E, et al. Clinical, parasitological and molecular profiles of cutaneous leishmaniasis and its associated factors among clinically suspected patients attending Borumeda hospital, North-East Ethiopia. PLoS Negl Trop Dis 2020; 14: 1–13.
- 36Beyene HB, Alemu M, Degife M. Prevalence and clinical features of cutaneous leishmaniasis in Dembidolo District, Western Ethiopia: a cross-sectional study. Int J Infect Trop Dis 2015; 2: 31–38.
10.14194/ijitd.2.1.4 Google Scholar
- 37Bsrat A, Berhe N, Balkew M, et al. Epidemiological study of cutaneous leishmaniasis in Saesie Tsaeda-emba district, eastern Tigray, northern Ethiopia. Parasit Vectors 2015; 8: 1–9.
- 38Tilahun F, Alemu W, Mulatu G. Magnitude and associated factors of cutaneous leishmaniasis; in Mekelle city, Ayder referral hospital,Tigray, northern Ethiopia. Clin Med Res 2014; 3: 189–199.
10.11648/j.cmr.20140306.16 Google Scholar
- 39Mengistu G, Laskay T, Gemetchu T, et al. Cutaneous leishmaniasis in South-Western Ethiopia: Ocholo revisited. Tran Rsoci Tmed and Hig 1992; 8: 149–153.
- 40Bugssa G, Hailu H, Demtsu B. The current status of cutaneous leishmaniasis and the pattern of lesions in Ochollo primary school students, Ochollo, southwestern Ethiopia. Sci J Clin Med 2014; 3: 111–116.
10.11648/j.sjcm.20140306.13 Google Scholar
- 41Yohannes M, Abebe Z, Boelee E. Prevalence and environmental determinants of cutaneous leishmaniasis in rural communities in Tigray, northern Ethiopia. PLoS Negl Trop Dis 2019; 13: 1–14.
- 42Berhe N, Balkew M, Gebre-Michael T, et al. Leishmaniasis in the middle course of the Ethiopian Rift Valley: I. clinical and leishmanin skin test surveys. Ethiop Med J 1998; 36: 113–122.
- 43Wilkins HA. Studies on leishmaniasis in Ethiopia. VI. Incidence rates of cutaneous leishmaniasis at meta abo. Ann Trop Med Parasitol 1972; 66: 457–466.
- 44Lemma A, Foster W, Gemetchu T, et al. Studies on leishmaniasis in Ethiopia. I. Preliminary investigations into the epidemiology of cutaneous leishmaniasis in the highlands. Ann Trop Med Parasitol 1969; 63: 455–472.
- 45Mengistu G, Humber DP, Ersumo M, et al. High prevalence of elephantiasis and cutaneous leishmaniasis in Ocholo, south-West Ethiopia. Ethiop Med J 1987; 25: 203–207.
- 46Neway S, Yeshitila B, Mebrat B, et al. Prevalence of cutaneous leishmaniasis in alert center, retrospective analysis, Addis Ababa. J Health Syst Policies 2021; 3: 110–121.
10.52675/jhesp.949565 Google Scholar
- 47Morronea A, Pitidis A, Pajnoa MC, et al. Epidemiological and geographical aspects of leishmaniasis in Tigray, northern Ethiopia: a retrospective analysis of medical records, 2005–2008. Trans R Soc Trop Med Hyg 2011; 105: 273–280.
- 48Bekele S, Bekele Y, Mulatu F, et al. Recent trends of cutaneous leishmaniasis in alert hospital, Addis Ababa. Ethiop Med J 2014; 1: 1–11.
- 49Fkhara M, Motazedian MH, Hatam GR, et al. (2008) asymptomatic human carriers of leishmania infantum: Possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran. Ann Trop Med Parasitol 2008; 7: 577–583.
10.1179/136485908X337526 Google Scholar
- 50Karimkhani C, Wanga V, Coff Eng LE, et al. Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the global burden of disease study 2013. Lancet Infect Dis 2016; 16: 1–8.
- 51Aksoy M, Doni N, Ozkul HU, et al. Pediatric cutaneous leishmaniasis in an endemic region in Turkey: a retrospective analysis of 8786 cases during 1998–2014. PLoS Negl Trop Dis 2016; 10: 1–11.
- 52Ngere I, Boru WG, Isack A, et al. Burden and risk factors of cutaneous leishmaniasis in a peri-urban settlement in Kenya, 2016. PLoS One 2020; 15: 1–17.
- 53Blanco VM, Cossio A, Martinez JD, et al. Clinical and epidemiologic profile of cutaneous leishmaniasis in Colombian children: considerations for local treatment. Am J Trop Med Hyg 2013; 89: 359–364.
- 54Eshetu B, Mamo H. Cutaneous leishmaniasis in north-Central Ethiopia: trend, clinical forms, geographic distribution, and determinants. Trop Med Health 2020; 48: 1–10.
- 55Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med 2016; 9: 925–932.
Citing Literature
